MedPath

Protective Ventilation During Pulmonary Lobectomy

Not Applicable
Conditions
Pulmonary Complication
Thoracic Surgery
Inflammation
Registration Number
NCT03174743
Lead Sponsor
Xuzhou Medical University
Brief Summary

The investigator will evaluate the influence of lung protective ventilation on postoperative clinical outcome in patients undergoing one-lung ventilation for pulmonary lobectomy.

Detailed Description

The hypothesis is that application of low tidal volume, moderate inspired oxygen fraction (FiO2) ,intermittent alveolar recruitment and positive end-expiratory pressure (PEEP) would be more beneficial than conventional ventilation in patients.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
120
Inclusion Criteria

1.20 Years and older 2.Patients undergoing pulmonary lobectomy

Exclusion Criteria
  1. Emergency surgery
  2. Pulmonary hypertension
  3. Forced vital capacity or forced expiratory volume in 1 sec < 50% of the predicted values
  4. Coagulation disorder
  5. Pulmonary or extrapulmonary infections
  6. History of treatment with steroid in 3 months before surgery
  7. History of recurrent pneumothorax
  8. History of lung resection surgery

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
The proportion of patients with pulmonary complicationup to postoperative 3days

The number of patients with pulmonary complication including atelectasis, pulmonary infiltration, pulmonary edema, pulmonary infection, pleural effusion and pulmonary embolism.

Secondary Outcome Measures
NameTimeMethod
IL610 min after induction, 60 min after start of one-lung ventilation, 15 min after restart of two-lung ventilation
IL1010 min after induction, 60 min after start of one-lung ventilation, 15 min after restart of two-lung ventilation
PaO2 /FiO210 min after induction, 30 and 60 min after start of one-lung ventilation, 15 min after restart of two-lung ventilation, 1 hour after the end of surgery
respiratory compliance10 min after induction, 30 and 60 min after start of one-lung ventilation, 15 min after restart of two-lung ventilation

Dynamic compliance, Static compliance

Trial Locations

Locations (1)

The Affiliated Hospital of Xuzhou Medical University

🇨🇳

Xuzhou, Jiangsu, China

The Affiliated Hospital of Xuzhou Medical University
🇨🇳Xuzhou, Jiangsu, China
Liu Su Liu, MD/Ph.D
Contact
+86-18118309692
xyfymzk@163.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.